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        Terms such as positive selection and deletion are 
most commonly used to describe events occur-
ring during thymocyte development. Thymo-
cytes that have not correctly rearranged their 
TCRs undergo a process referred to as death 
by neglect and do not survive (  1  ). Although 
NK cells are not generally thought to undergo 
such selective processes, recent evidence suggests 
that developing NK cells may be   “  licensed  ”   or 
  “  armed  ”   in the bone marrow to acquire a fully 
functional status (  2  –  6  ). Similar to positive selec-
tion of immature T cells that have correctly re-
arranged a functional TCR able to interact with 
self-peptide  –  MHC, immature NK cells express-
ing inhibitory receptors may be given the 
proper signals via interactions with their autolo-
gous MHC class I molecules to complete their 
functional maturation (  2, 3  ). In the absence 
of these interactions, NK cells may either fail to 
complete their maturation or, alternatively, may 
be chronically stimulated, with each case resulting 
in NK cells that are hyporesponsive (  2, 3  ). There-
fore, selective pressures apparently are placed on 
immature NK cells expressing inhibitory recep-
tors to ensure self-tolerance. 
  NK cells expressing activating receptors might 
also undergo a selection process that would elim-
inate or inactivate developing NK cells bearing 
an activating receptor recognizing a high affi   n-
ity ligand expressed in the host  ’  s bone marrow 
in a manner similar to negative selection in thy-
mocytes. NK cells bearing the DAP12-associ-
ated activating Ly49H receptor interact with the 
mouse CMV (MCMV)  –  encoded protein m157 
on infected cells (  7, 8  ), thus protecting mice 
containing this NK cell subset against MCMV 
infection (  9  ). In a specifi  c pathogen-free mouse 
colony, immature NK cells will not encounter 
this viral ligand during development in the bone 
marrow. This provides a model system to deter-
mine how immature Ly49H  +   NK cells behave 
when they encounter a ligand for an activating 
receptor during development. Would immature 
Ly49H  +   NK cells be deleted in a manner analo-
gous to thymocytes that have rearranged a self-
reactive TCR? Would these NK cells mature and 
become chronically activated in the periphery? 
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  During development, T and B cells encountering their cognate ligands via antigen-specifi  c 
receptors are deleted or rendered anergic. Like T and B cells, natural killer (NK) cells ex-
press certain receptors, such as Ly49H, associated with immunoreceptor tyrosine-based 
activation motif  –  bearing adaptor proteins that transmit activating signals through Syk 
family kinases. Ly49H binds with high affi  nity to a mouse cytomegalovirus (MCMV)  –
  encoded glycoprotein, m157, but does not recognize self-antigens. For comparison with 
the behavior of immature T and B cells exposed to foreign antigens, we addressed the fate 
of Ly49H  +   NK cells that encountered their viral ligand during development by retroviral 
transduction of bone marrow stem cells with m157. In chimeric mice expressing m157, we 
observed a reduction in Ly49H  +   NK cells in multiple tissues and less Ly49H on the cell 
surface. NK cells exposed to m157 during development appeared less mature, produced less 
interferon      when stimulated through Ly49H, and were unable to kill m157-bearing target 
cells. After MCMV infection, these NK cells were severely impaired in their ability to 
proliferate. Thus, if immature NK cells encounter ligands for their activating receptors, 
regulatory mechanisms exist to keep these cells in an unresponsive state. 
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of m157 by transient transfection of 293T cells and co-culturing 
with an Ly49H-NFAT-GFP reporter cell line. m157-trans-
fected 293T cells activated   >  70% of   reporter cells, as measured 
by GFP expression (  Fig. 1 A  ).     Using an antibody specifi  c for 
m157 (  13  ), we demonstrated expression of this viral protein 
on the surface of packaging cells transfected with the Mig-
m157 vector, on hematopoietic stem cells infected with the 
Mig-m157 retrovirus, and on bone marrow cells from lethally 
irradiated B6 mice reconstituted with m157 retrovirus  –  infected 
hematopoietic stem cells 3 mo after transplantation (  Fig. 1 B  ). 
In contrast, m157 was not detected on cells from the Mig vec-
tor control group (  Fig. 1 B  ). 
  Ly49H  +   NK cell numbers and Ly49H expression are reduced 
in m157-expressing mice 
  NK cells in peripheral blood from the chimeric mice express-
ing m157 or the control vector were analyzed. Because stem 
cells derived from congenic CD45.1 mice were injected into 
irradiated CD45.2 recipient mice, donor cells were tracked 
by staining with an antibody against CD45.1 (  Fig. 2 A  ).   Pe-
ripheral blood revealed a   >  50% reduction in the percentage 
of Ly49H  +   NK cells from m157-expressing mice compared 
with Mig control mice, whereas the numbers of NK cells 
bearing another DAP12-associated activating receptor, Ly49D, 
were unchanged (  Fig. 2 A  ). Ly49D and Ly49H are coexpressed 
on a subset of double-positive cells (  14  ); interestingly, the 
percentage of these double-positive NK cells was diminished, 
replaced by an increased frequency of single-positive Ly49D  +   
NK cells (Fig. S1, available at http://www.jem.org/cgi/content/
full/jem.20072448/DC1). Furthermore, surface Ly49H ex-
pression, as measured by the mean fl  uorescence intensity (MFI) 
of cells stained with anti-Ly49H mAb, was diminished on 
NK cells from Mig-m157 mice compared with Mig control 
mice (  Fig. 2 B  ). As a control, the amount of Ly49D on NK 
cells was similar between the two groups (  Fig. 2 B  ), even on 
the Ly49D  +  , Ly49H  +   double-positive NK cells, suggesting that 
the lower expression of Ly49H observed in Mig-m157 mice 
is specifi  c to the expression of the Ly49H ligand. Similarly, 
NKG2D was expressed at similar levels in the two groups 
(  Fig. 2 B  ). NK cell subsets expressing inhibitory receptors 
also showed no diff  erences between m157-expressing and 
control mice (Fig. S2). In addition, expression of inhibitory 
Ly49 receptors on the Ly49H  +   NK cell subset from m157-
expressing mice showed no diff  erences compared with control 
mice (unpublished data). Reduced Ly49H  +   NK cell numbers 
and Ly49H expression were observed in the peripheral blood 
of m157-expressing mice at multiple time points after stem 
cell reconstitution (  Fig. 2 C  ). 
  3 mo after reconstitution, m157-expressing and control 
Mig mice were killed, and the NK cells from multiple organs 
were analyzed. The overall number of NK cells in all organs 
showed no signifi  cant diff  erences between the two groups 
(unpublished data). Similar to peripheral blood, Ly49H  +   NK 
cell numbers and Ly49H surface expression were reduced in 
the spleen, liver, and bone marrow of m157-expressing com-
pared with control mice (  Fig. 3 A  ).   Ly49D  +   NK cell numbers 
Would these NK cells be desensitized to the ligand and 
become hyporesponsive when challenged with infection dur-
ing adult life? 
  Studies to determine how T and B cells respond when 
exposed to high affi   nity foreign   antigen during development 
have typically used TCR or BCR transgenic mice against an-
tigens such as ovalbumin or hen egg lysozyme (  10, 11  ). Be-
cause the Ly49H receptor has a high affi     nity for the viral 
glycoprotein m157 but does not recognize any self-antigen 
(  12  ), this provides an analogous model system to evaluate the 
fate of NK cells receiving strong immuno  receptor tyrosine-
based activation motif (ITAM)  –  mediated signaling during 
development. To address this question, we generated mice 
that express m157 in the bone marrow and examined the 
development of the Ly49H  +   NK cell subset. To our surprise, 
we observed that Ly49H  +   NK cells were found in the pe-
riphery of m157-expressing mice; however, these NK cells 
were present at lower numbers and were severely defective in 
their ability to mediate cytotoxicity and proliferate in re-
sponse to MCMV infection. 
    RESULTS   
  Expression of m157 in cell lines and chimeric mice 
  The goal of this study was to determine the eff  ects of early and 
chronic stimulation of the Ly49H receptor with its viral ligand, 
m157, on the development and function of NK cells. We cloned 
m157 into the MigR1 retroviral vector and assessed expression 
    Figure 1.         Expression of MCMV-encoded m157 protein in cell 
lines and stem cell chimeric mice.   (A) 293T cells transfected with Mig 
control vector or Mig-m157 were co-cultured with the Ly49H-NFAT-GFP 
reporter cell line. Percentages of reporter cells expressing GFP are shown. 
(B) m157 expression in transfected Phoenix E cells, retrovirus-infected 
bone marrow cells, and bone marrow cells from hematopoietic stem 
cell  –  reconstituted irradiation chimeric mice was measured by using an 
antibody against m157. Cells expressing m157 in the cells infected with 
Mig control vector and the Mig-m157 construct are shown. The effi  -
ciency of transduction with the control Mig and the Mig-m157 vectors, 
as determined by GFP expression, was comparable (not depicted).     JEM VOL. 205, August 4, 2008 
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expressing animals. Therefore, the decrease in the percentage 
of Ly49H  +   NK cells in the m157-expressing mice is not sim-
ply caused by an inability to discriminate between the Ly49H 
positive and negative subsets. 
  Ly49H  +   NK cells from m157-expressing mice are 
phenotypically less mature 
  NK1.1 is expressed early on immature NK cells, before ex-
pression of the Ly49 receptors (  15  –  17  ). No diff  erences were 
observed in the amounts of NK1.1 expressed on Ly49H  +   NK 
and Ly49D expression remained unchanged between the two 
groups (unpublished data). NKG2D was also unaff  ected on 
NK cells in all tissues examined from m157-expressing or 
control mice (  Fig. 3 A  ). Although the percentages of Ly49H  +   
NK cells were diminished by   >  60% in the spleen and liver of 
m157-expressing mice, only a small decrease was observed in 
the bone marrow (  Fig. 3 B  ). It should be noted that although 
the amount of Ly49H on the surface of the NK cells in the m157-
expressing mice was lower than in control mice, the Ly49H  +   
and Ly49H        subsets were still clearly resolved in the m157-
    Figure 2.         Reduced Ly49H  +   NK cell numbers and Ly49H expression 
in the peripheral blood of m157-expressing chimeric mice.   (A) 28 d 
after reconstitution of irradiated recipient mice with Mig control or Mig-
m157  –  transduced stem cells (CD45.1  +  ), peripheral blood was analyzed 
for Ly49H  +   and Ly49D  +   NK cells in chimeric mice. Plots are gated on 
CD3      ,  NK1.1 +   cells, and percentages of Ly49H  +   (top) and Ly49D  +   (bottom) 
NK cells (CD45.1  +  ) are shown. MFIs for boxed regions are shown in pa-
rentheses. (B) Overlay of histogram plots comparing cell surface amounts 
of Ly49H, Ly49D, and NKG2D on NK cells that express the activating re-
ceptor from Mig control and Mig-m157 chimeric mice. (C) Graphs show 
the percentages of Ly49H  +   cells (left) and the MFI for Ly49H expression 
(right) at 12, 28, and 75 d after reconstitution of irradiated recipient 
mice. Data are presented as the mean   ±   SEM of three to fi  ve mice at 
each time point. Statistical differences in the percentage of Ly49H  +   NK 
cells and the MFI of Ly49H expression between control and m157-ex-
pressing mice are indicated (*, P   <   0.01; **, P   <   0.001; ***, P   <   0.0001). 
Data are representative of three independent experiments.     
    Figure 3.         Reduced Ly49H  +   NK cell numbers in the spleen, liver, 
and bone marrow of m157-expressing mice.   3 mo after hematopoietic 
stem cell reconstitution of irradiated recipient mice with either Mig con-
trol or Mig-m157  –  transduced stem cells, mice were killed and NK cells 
from the spleen, liver, and bone marrow were analyzed. (A) Plots show the 
percentages of CD3      ,  NK1.1 +   cells from the indicated organs that express 
Ly49H and NKG2D. (B) Bar graph shows the percentages of Ly49H  +   NK 
cells in tissues examined, presented as the mean   ±   SEM of three to fi  ve 
mice. Differences in percentages of Ly49H  +   NK cells between control and 
m157-expressing mice were statistically signifi  cant in the spleen and liver 
(P   <   0.01). Data are representative of three independent experiments.     1822 NK CELL TOLERANCE   | Sun and Lanier 
remained higher on Ly49H  +   NK cells from m157-expressing 
compared with control mice, with the sharpest contrast seen in 
the bone marrow (  Fig. 4 A  ). Other markers expressed at high 
levels late during NK cell maturation, such as CD43 and 
CD11b (Mac-1) (  16  –  18  ), were present at lower amounts on 
Ly49H  +   NK cells from m157-expressing mice compared with 
controls (  Fig. 4 B  ). In m157-expressing mice, Ly49H        NK 
cells did not appear phenotypically immature compared with 
controls, indicating a preferential eff  ect on the development of 
the Ly49H  +   NK cells (unpublished data). Collectively, these 
results suggest that NK cells encountering m157 during 
development do not properly mature. 
  Ly49H  +   NK cells from m157-expressing mice produce less 
IFN-     and exhibit diminished cytotoxicity ex vivo 
  Because of the altered phenotype of the Ly49H  +   NK cells from 
m157-expressing mice, we tested the functionality of these 
cells ex vivo. Splenocytes were incubated with plate-bound 
antibodies against NK1.1, Ly49D, or Ly49H for 4 h in the 
presence of Brefeldin A, and intracellular IFN-     production 
was measured. Although anti-NK1.1 and anti-Ly49D stimula-
tion gave comparable numbers of IFN-      –  producing NK cells 
between m157-expressing and control mice, anti-Ly49H stim-
ulation resulted in robust IFN-     production only by NK cells 
from Mig control mice and not NK cells from m157-express-
ing mice (  Fig. 5  ).   However, this selective hyporesponsiveness 
to anti-Ly49H mAb stimulation was partially rescued if the 
NK cells from m157-expressing mice were cultured in the 
presence of high concentrations of IL-2 (Fig. S3, available at 
http://www.jem.org/cgi/content/full/jem.20072448/DC1). 
  We tested the ability of Ly49H  +   NK cells from 28-d bone 
marrow  –  reconstituted control and m157-expressing mice to 
kill m157-bearing target cells. Splenocytes from both groups 
of mice were enriched for NK cells by using magnetic bead 
cell sorting. Comparable numbers of Ly49H  +   NK cells (as 
determined by fl  ow cytometry) were coincubated with m157-
transduced Ba/F3 targets or untransduced Ba/F3. Although 
Ly49H  +   NK cells from Mig control mice were able to effi   -
ciently lyse m157-bearing target cells, Ly49H  +   NK cells from 
m157-expressing mice showed a severely diminished cytotoxic 
response (  Fig. 6 A  ).   At 3 mo after reconstitution, Ly49H  +   
NK cells from m157-expressing mice continued to show a 
decreased ability to kill BaF3-m157 target cells compared 
with Mig control mice (  Fig. 6 B  ). Overall, NK cell  –  mediated 
cytotoxicity in m157-expressing mice remained intact because 
lysis of Ba/F3 targets expressing Rae-1     (an NKG2D ligand) 
or YAC-1 targets was comparable to control mice (  Fig. 6, C 
and D  ). Together with the cytokine data, these experiments 
demonstrate that NK cells that develop in the presence of 
m157 show severely diminished eff  ector functions when 
stimulated through the Ly49H receptor. 
  Reduced expansion of activated Ly49H  +   NK cells 
from m157-expressing mice 
  Because the Ly49H  +   NK cells from m157-expressing mice 
were less responsive in vitro when stimulated with anti-Ly49H 
cells in the spleen, liver, and bone marrow from m157-express-
ing mice and control mice (  Fig. 4 A  ).   Other receptors expressed 
before the Ly49 receptors, such as CD122 (  15  –  17  ), were unal-
tered on Ly49H  +   NK cells from m157-expressing compared 
with control Mig mice (unpublished data). Expression of CD117 
(c-Kit), a developmental marker that is turned on after Ly49H 
expression but then down-regulated as NK cells mature (  15  –  17  ), 
    Figure 4.         Ly49H  +   NK cells in the spleen, liver, and bone marrow of 
m157-expressing mice are phenotypically less mature.   (A)  Histo-
grams show the expression of the developmental markers NK1.1 (top) and 
c-Kit (bottom) on Ly49H  +   NK cells in the spleen, liver, and bone marrow of 
Mig control or Mig-m157 chimeric mice. (B) Plots show expression of the 
maturation markers CD43 and CD11b (Mac-1) on Ly49H  +   NK cells in the 
spleen, liver, and bone marrow of Mig control or Mig-m157 chimeric 
mice. Quadrant markers were arbitrarily set to allow visual comparison of 
the most mature NK cell populations that coexpressed high amounts of 
both CD43 and Mac-1 in the different tissues. Percentages are shown for 
each quadrant in the dot plots. Data are representative of three indepen-
dent experiments, with three to fi  ve mice per group.     JEM VOL. 205, August 4, 2008 
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http://www.jem.org/cgi/content/full/jem.20072448/DC1); 
however, the transferred NK cells (CD45.1  +  ) analyzed 36 h 
after MCMV infection showed very little expansion in the 
spleen at this early time point (not depicted). Interestingly, 
7 d after infection, the Ly49H  +   NK cells from m157-ex-
pressing mice were unable to expand as well as their coun-
terpart Ly49H  +   NK cells from control Mig mice (  Fig. 7 C  ). 
The endogenous Ly49H  dim   population (CD45.1       ) found in 
DAP12-defi  cient recipients demonstrate much less expan-
sion in response to MCMV and remain at   <  50% of the entire 
NK cell pool (  Fig. 7 C   and not depicted). After infection, 
Ly49H  +   NK cells from both m157-expressing and control 
mice expressed high amounts of KLRG1 on the cell surface 
(  Fig. 7 C  ), signifying activation of these proliferating cells 
(  20  ). The adoptively transferred Ly49H  +   NK cells from con-
trol Mig mice expanded 5  –  10-fold (a statistically signifi  cant 
amount; P = 0.004) more than the Ly49H  +   NK cells from 
m157-expressing mice in response to MCMV infection (  Fig. 
7 D  ). These experiments demonstrate that Ly49H  +   NK cells 
exposed to their cognate viral ligand during development 
are defective in their ability to   “  sense  ”   m157 during MCMV 
infection and respond in a rapid manner. 
  In these studies, we examined the in vivo response of 
the NK cells from control Mig or Mig-m157 mice to MCMV 
by adoptive transfer, rather than by simply challenging the 
chimeric mice with MCMV, for several reasons. The adop-
tive transfer experiments allowed us to match the number 
of transferred control and m157-exposed NK cells in the 
or co-cultured with m157-bearing target cells, we tested the 
in vivo functionality of these cells. Splenic NK cells from 
irradiation bone marrow chimeric mice expressing m157 or 
vector control were purifi  ed and adoptively transferred into 
DAP12-defi  cient recipient mice (  Fig. 7 A  ).   We have previ-
ously shown that in DAP12-defi  cient mice, Ly49H is ex-
pressed at much lower levels than in wild-type mice (  19  ). 
We then measured the activation and proliferation of the 
transferred wild-type Ly49H  +   NK cells from m157-express-
ing or control mice after MCMV infection (  Fig. 7 A  ). Donor 
Ly49H  +   NK cell numbers were normalized before injection 
so that the same percentage of Ly49H  +   cells was present in 
the NK cell population of the recipient mice before infection 
(  Fig. 7 B  ). The donor Ly49H  +   NK cells from m157-express-
ing mice remained Ly49H  lo   even after adoptive transfer into 
recipient mice (  Fig. 7 B  ). NK cells from both control and 
m157-expressing mice displayed the typical early activation 
profi  le attributable to the massive infl  ammatory response 
induced immediately after viral infection (Fig. S4, available at 
    Figure 5.         NK cells from m157-expressing mice produce less IFN-     
when stimulated with anti-Ly49H.   Freshly isolated splenocytes 
from either Mig control or m157-expressing mice were stimulated with 
plate-bound antibodies against the NK cell surface markers NK1.1, 
Ly49D, Ly49H, or control (no antibody). Plots show the percentages of 
CD3      ,  CD11b + ,  DX5 +   cells that produce IFN-    . Data are representative 
of three independent experiments.     
    Figure 6.         Ly49H  +   NK cells from m157-expressing mice exhibit 
diminished cytotoxicity against m157-bearing targets.   NK cells from 
Mig control or Mig-m157 chimeric mice at 28 d (A) or 3 mo (B) after re-
constitution were MACS purifi  ed. Equivalent numbers of Ly49H  +   NK  cells, 
as determined by fl  ow cytometry, were incubated with Ba/F3 or m157-
transfected Ba/F3. (C) Total NK cells from Mig or Mig-m157 mice were 
incubated with Ba/F3 or Rae-1  –  transfected Ba/F3 target cells. (D) Total 
NK cells from Mig or Mig-m157 mice were incubated with YAC-1 target 
cells. Data are representative of three independent experiments.     1824 NK CELL TOLERANCE   | Sun and Lanier 
vector control mice (  Fig. 8 A  ). In contrast, no diff  erences in 
Ly49D  +   NK cell numbers or Ly49D surface expression were 
observed between the three groups (  Fig. 8 A  ). When gating on 
Mig-control (CD45.2  +  ) or Mig-m157 (CD45.1  +  ) cells within 
NK cell populations from 1:1 mixed chimeras, similarly dimin-
ished Ly49H expression was observed at days 12 and 28 after 
reconstitution compared with NK cells from control Mig mice 
(  Fig. 8 B  ). These fi  ndings suggest that the regulatory eff  ects of 
m157 on the Ly49H  +   NK cell population can occur in trans 
and that expression of m157 does not have to be intrinsic to 
the NK cell being rendered less responsive. 
    DISCUSSION   
  The innate immune system is evolutionarily older than the 
adaptive immune system. Although NK cells are considered 
members of the innate immune system, they bear many strik-
ing phenotypic and functional similarities to T cells (  21  –  23  ). 
NK cells might constitute a lineage of cells that provides an 
evolutionary link between the innate immune system and the 
antigen-specifi  c receptor-bearing cells of adaptive immunity, 
possessing certain attributes of both. If NK cells are indeed a 
bridge between innate and adaptive immunity, then hallmarks 
of the adaptive immune system may have evolved fi  rst in 
this cell type. In fact, the paradigm is beginning to shift, given 
  recipient mice. Moreover, if we had simply infected the Mig-
m157 chimeric mice with MCMV, the host hematopoietic 
cells in the mice would express m157 so that the Ly49H  +   NK 
cells would be unable to distinguish between MCMV-infected 
and normal host cells expressing the transduced m157. 
  Inhibition of Ly49H  +   NK cell maturation in trans 
by cells expressing m157 
  To determine whether the immature phenotype and hypore-
sponsiveness of Ly49H  +   NK cells from m157-expressing mice 
could be caused by expression of m157 on an adjacent cell dur-
ing development, we made 1:1 Mig/Mig-m157 mixed bone 
marrow chimeric mice and compared NK cell populations 
with m157-expressing and control Mig mice. To track indi-
vidual cell populations in 1:1 mixed chimeras, Mig-infected 
control bone marrow was derived from B6 (CD45.2  +  ) mice, 
and m157-expressing bone marrow was derived from con-
genic CD45.1 mice. Peripheral blood on day 28 after reconsti-
tution revealed a   >  50% reduction in the percentage of Ly49H  +   
NK cells from 1:1 mixed chimeras compared with Mig control 
mice, with percentages similar to Ly49H  +   NK cell numbers 
from m157-expressing mice (  Fig. 8 A  ).   Similar to m157-ex-
pressing mice, surface Ly49H expression was diminished on all 
NK cells from 1:1 mixed chimeric mice compared with Mig 
    Figure 7.         Reduced expansion of Ly49H  +   NK cells from m157-expressing mice.   (A) Schematic diagram of experiment. NK cells from Mig control or 
m157-expressing mice were MACS purifi  ed, and equivalent numbers of Ly49H  +   NK cells were adoptively transferred to DAP12-defi  cient recipient mice. 
Recipient mice were infected with MCMV 1 d later. Splenic NK cells were analyzed 36 h and 7 d after infection. (B) Plots show transferred NK cells 
(CD45.1  +  ) in the spleen of recipient DAP12-defi  cient (CD45.2  +  ) mice before infection. Percentages of Ly49H  +   cells within the total NK cell population are 
found in the gated region of each plot. (C) Plots show transferred NK cells (CD45.1  +  ) in recipient DAP12-defi  cient mice 7 d after MCMV infection. Percent-
ages of Ly49H  +   cells within the total NK cell population are gated in each plot. Activation marker KLRG1 was measured on total transferred NK cell popu-
lations. (D) Expansion of the transferred Ly49H  +   NK cells is shown in the graphs. The percentages of transferred Ly49H  +   cells in the entire NK cell 
population (left) and the absolute number of transferred Ly49H  +   NK cells (right) are plotted for 0, 1.5, and 7 d after infection. Data are presented as the 
mean   ±   SEM of two or three mice at each time point. Differences in the percentage and absolute number of Ly49H  +   NK cells between control and m157-
expressing mice were statistically signifi  cant at day 7 after infection (P = 0.004). Data are representative of three independent experiments.     JEM VOL. 205, August 4, 2008 
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that immature NK cells undergo selective events in the bone 
marrow that determine their fate in the periphery. The ques-
tion of whether developing NK cells bearing activating recep-
tors experience similar selective pressures was unaddressed. 
Therefore, we sought to determine whether self-tolerance oc-
curs in developing NK cells bearing ITAM-signaling activat-
ing receptors in a manner similar to developing T or B cells. 
  For comparison with previous studies using TCR or BCR 
transgenic mice exposed to high affi   nity antigens during 
development, we established a model system whereby the 
ITAM-signaling Ly49H receptor expressed on NK cells would 
encounter the foreign m157 glycoprotein during their develop-
ment in the bone marrow. Using this model, we demon-
strate that when developing Ly49H  +   NK cells encounter their 
cognate viral ligand, certain regulatory mechanisms render 
the cells in the periphery hyporesponsive. Rather than a com-
plete deletion, as seen in thymocytes possessing TCRs that 
undergo high affi   nity interactions with self-peptide  –  MHC 
complexes (  Fig. 9 A  ), Ly49H  +   NK cells that interact with 
m157 survive but populate the periphery in lower numbers 
and express diminished amounts of the Ly49H receptor on 
the cell surface.   Furthermore, these Ly49H-bearing NK cells 
from mice that express m157 were defective in their ability 
produce eff  ector cytokines and mediate killing via Ly49H-
specifi  c stimulation and to specifi  cally expand after MCMV 
infection. Perhaps the term   “  disarming  ”   is best applied to 
these activating receptor  –  bearing NK cells that are actively 
rendered hyporesponsive by bone marrow  –  derived cells ex-
pressing cognate ligand for Ly49H (  Fig. 9 B  ). Just as NK cells 
lacking inhibitory receptors for self  –  MHC class I can exit the 
bone marrow and populate the periphery but are refractory 
to stimulation through their activating receptors, disarmed 
NK cells bearing activating receptors that have encountered 
their cognate ligand during development undergo a similar 
fate (  Fig. 9 B  ). Interestingly, there is a small population of 
Ly49H  +   NK cells that eludes tolerance in our system, and 
they can produce cytokines (  Fig. 5  ) and undergo proliferative 
expansion (  Fig. 7  ) via specifi  c Ly49H receptor ligation. Fur-
ther studies are required to determine the mechanism of this 
escape and establish whether or not these NK cells behave 
similarly to self-reactive T cells that have evaded central toler-
ance mechanisms and are either rendered anergic or mediate 
autoimmunity in the periphery. 
  We have used m157 as a model system to evaluate the 
consequences of early exposure of NK cells during their de-
velopment to a high affi   nity non  –  self-ligand for an ITAM-
bearing receptor. Although MCMV persists in the host after 
resolution of the primary infection, MCMV is preferentially 
localized in the salivary gland. Therefore, it is unlikely that 
NK cells, which develop predominantly in the bone mar-
row, would encounter cells expressing m157 during their early 
development. Our present studies do not address the conse-
quences of prolonged exposure of mature NK cells, as com-
pared with developing NK cells, to m157. In adult mice infected 
with MCMV, there is expansion of mature Ly49H  +   NK cells, 
followed by a contraction phase in which most of these NK 
recent data documenting selective pressures on developing 
NK cells (  2, 3  ), clonal expansion of NK cell subsets (  24  –  26  ), 
and possibly even immune memory in NK cells (  27  ). 
  Although T cell development is relatively well under-
stood, little is known about how NK cells are regulated during 
their development (  21  –  23  ). Recently, two groups have pro-
posed comparable, yet distinct, models for mechanisms that 
regulate the development of NK cells bearing inhibitory re-
ceptors for self  –  MHC class I (  2, 3  ). Although the precise 
mechanism for self-tolerance is yet to be determined, it is clear 
    Figure 8.         Expression of m157 results in trans down-regulation of 
Ly49H expression and Ly49H    +     NK cell numbers.   (A) 28 d after hema-
topoietic stem cell reconstitution of irradiated recipient mice with Mig 
control, Mig-m157, or a 1:1 mixture of Mig control/Mig-m157 stem cells, 
peripheral blood was analyzed for Ly49H  +   and  Ly49D +   NK cells in mixed 
chimeric mice. Plots are gated on CD3      ,  NK1.1 +   cells, and percentages of 
NKG2D  +   Ly49H +   (top) and Ly49D  +   (bottom) NK cells are shown. MFIs for 
boxed regions are shown in parentheses. (B) Overlay histogram plots ex-
amine the amounts of Ly49H on the cell surface of NK cells derived from 
Mig control (CD45.2  +  ) and Mig-m157 (CD45.1  +  ) stem cell populations 
within the 1:1 mixed chimeric mice. Peripheral blood from 12 and 28 d 
after reconstitution are shown. Data are representative of three indepen-
dent experiments, with three to fi  ve mice per group at each time point.     1826 NK CELL TOLERANCE   | Sun and Lanier 
expressed by the strong     -actin promoter in the transgenic 
mice compared with the lower amounts of m157 produced 
by the retroviral vector. Nonetheless, the major conclusions 
from both of these complementary studies are in agreement. 
  Previous studies have examined the consequences of 
transgenic expression of ligands for certain other NK cell re-
ceptors. In transgenic B6 mice constitutively expressing Rae-
1, NKG2D (a receptor for Rae-1) was down-regulated on 
developing and mature NK cells (  30, 31  ). These transgenic 
mice were unable to reject Rae-1  –  bearing tumors that are re-
jected by syngeneic, nontransgenic mice and were unable to 
reject allogeneic bone marrow grafts expressing Rae-1. Our 
current study fundamentally diff  ers from these experiments 
involving NKG2D ligand expression in several ways. Rae-1 is 
a self-protein, whereas m157 is foreign. Moreover, although 
Rae-1 is not expressed in most healthy adult tissues, we have 
detected constitutive expression of Rae-1 in the liver, a site 
where NK cells are known to traffi   c (  32  ). In addition, the sig-
naling pathways used by Ly49H and NKG2D are distinct. 
  Previous studies have also investigated the DAP12-associ-
ated Ly49D receptor in mice bearing H-2D  d  , a ligand of 
Ly49D. In contrast to our fi  ndings with m157 and Ly49H, 
Ly49D  +   NK cells developing in a host expressing H-2D  d   
were not diminished in frequency or number (  33  ). More-
over, in mixed bone marrow chimeras in which B6 Ly49D  +   
cells presumably die by apoptosis (  24  –  26  ). Whether the re-
sponsiveness of the remaining MCMV-experienced NK cells 
is aff  ected has not yet been addressed. 
  Concurrent with our studies using retroviruses to express 
m157 in mice, Tripathy et al. generated m157-expressing 
transgenic mice (see Tripathy et al. [  28  ] on   p. 1829   of this 
  issue). In accordance with our fi  ndings, these investigators 
also observed a diminished number and functional impairment 
of Ly49H  +   NK cells in these m157-transgenic mice. In our 
adoptive transfer studies, we demonstrated a profound defect 
in the proliferation of Ly49H  +   NK cells from m157-express-
ing mice after recipient mice were infected with MCMV. 
This severe impairment in the expansion of these m157-
exposed Ly49H  +   NK cells would likely result in ineffi   cient 
clearance of MCMV in these hosts because the Ly49H  +   NK 
cell subset is known to be responsible for the NK cell  –  medi-
ated protection of B6 mice (  9, 25, 29  ). Indeed, Tripathy et al. 
(  28  ) have observed that m157-transgenic mice are more sus-
ceptible to MCMV infection than wild-type mice, with the 
lack of resistance attributed in part to the diminished cyto-
toxic function of Ly49H  +   NK cells in the transgenic mice. 
Although there were some diff  erences observed in these two 
experimental models (e.g., apparently a more profound im-
pairment of non-Ly49H receptors in the m157-transgenic 
mice), this might be accounted for by the amount of m157 
    Figure 9.         Regulatory events during T and NK cell development.   (A) Possible events and outcomes during T cell development in the thymus. Thymo-
cytes unable to interact with peptide-MHC do not survive and undergo death by neglect. Thymocytes interacting with peptide-MHC at low affi  nity 
are positively selected and survive to populate the periphery. Thymocytes interacting with peptide-MHC at high affi  nity will die by negative selection. 
(B) Possible events and outcomes during NK cell development in the bone marrow. Immature NK cells expressing inhibitory receptors that cannot interact 
with cognate MHC will survive but are hyporesponsive. Immature NK cells expressing inhibitory receptors are able to interact with cognate MHC and 
populate the periphery as functional effector cells. Immature NK cells expressing activating receptors do not interact with cognate ligand and will survive 
to become functional effector cells. Immature NK cells expressing activating receptors encounter cognate ligand and survive but are hyporesponsive.     JEM VOL. 205, August 4, 2008 
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provided by W. Yokoyama (Washington University, St. Louis, MO). Intra-
cellular IFN-     staining (BD Biosciences) was performed after in vitro culture 
in media containing Brefeldin A for 4 h at 37  °  C (  41  ). Flow cytometry was 
performed on an LSRII and data were analyzed with CellQuest software 
(both from Becton Dickinson). 
  Ex vivo NK cell stimulation assay.     2   ×   10  6   splenocytes were cultured 
in 24-well plates coated with the antibodies indicated in the fi  gures at 
10   μ  g/ml. Intracellular staining was performed after a 4-h incubation at 37  °  C 
in the presence of Brefeldin A. To avoid NK cell activation via CD16, cells 
were incubated with the neutralizing anti-CD16/32 mAb, 2.4G2, before 
performing stimulation assays. Because antibodies against NK1.1 were used 
in some experiments for stimulation, the percentages of IFN-      –  producing 
NK cells were determined by gating on CD3       , CD11b  +  , DX5  +   cells. 
  Ex vivo NK cell  –  mediated cytotoxicity assays.     Splenocytes were en-
riched for NK cells by using an NK cell isolation kit (Miltenyi Biotec) fol-
lowed by autoMACS magnetic bead separation. These ex vivo NK cells were 
used as eff  ector cells in a 6-h   51  Cr release assay (  42  ) against Ba/F3, m157-
transfected Ba/F3 (  7  ), YAC-1, and Rae-1      –  transfected Ba/F3 (  43  ) targets. 
  Adoptive transfer and MCMV infections.     NK cells were purifi  ed from 
the spleens of m157-expressing or control mice by using an NK cell isolation 
kit followed by autoMACS magnetic bead separation. 5   ×   10  5   Ly49H  +   NK 
cells from each group were adoptively transferred into DAP12-defi  cient re-
cipient mice. The following day, 5   ×   10  4   PFU of a salivary gland stock of 
MCMV (Smith strain) was injected i.p. 
  Statistical analysis.     Statistical diff  erences in percentage and absolute num-
ber of Ly49H  +   NK cells and MFI of Ly49H expression between control and 
m157-expressing mice were determined by using the two-tailed unpaired 
Student  ’  s   t   test. 
  Online supplemental material.     Fig. S1 shows specifi  c  Ly49H  +   and 
Ly49D  +   NK cell subsets in the peripheral blood and spleens of control and 
m157-expressing mice. Fig. S2 shows the expression of activating and inhib-
itory NK cell receptors in control and m157-expressing mice. Fig. S3 shows 
IFN-     production by NK cells from control and m157-expressing mice in 
the presence of anti-Ly49H mAbs and IL-2. Fig. S4 shows the early activa-
tion phenotype of Ly49H  +   NK cells from control and m157-expressing 
mice after MCMV infection. Online supplemental material is available at 
http://www.jem.org/cgi/content/full/jem.20072448/DC1. 
  We thank the Lanier laboratory for insightful comments and helpful discussions, 
and Joshua Beilke for critical review of this manuscript. We thank Wayne Yokoyama 
and Sandeep Tripathy for sharing their manuscript with us before publication. 
  National Institutes of Health grant AI068129 supported this work. J.C. Sun is 
supported by the Irvington Institute for Immunological Research. L.L. Lanier is an 
American Cancer Society Research Professor. 
  The authors have no confl  icting fi  nancial interests. 
Submitted:   16 November 2007 
Accepted:   21 March 2008 
  REFERENCES 
       1  .   Goldrath  ,   A.W.  , and   M.J.     Bevan  .   1999  .   Selecting and maintaining a 
diverse T-cell repertoire.       Nature      .     402  :  255    –    262  .    
       2  .   Kim  ,   S.  ,   J.     Poursine-Laurent  ,   S.M.     Truscott  ,   L.     Lybarger  ,   Y.J.     Song  , 
  L.     Yang  ,   A.R.     French  ,   J.B.     Sunwoo  ,   S.     Lemieux  ,   T.H.     Hansen  , and 
  W.M.     Yokoyama  .   2005  .   Licensing of natural killer cells by host major 
histocompatibility complex class I molecules.       Nature      .     436  :  709    –    713  .    
       3  .   Fernandez  ,   N.C.  ,   E.     Treiner  ,   R.E.     Vance  ,   A.M.     Jamieson  ,   S.     Lemieux  , 
and   D.H.     Raulet  .   2005  .   A subset of natural killer cells achieves self-
tolerance without expressing inhibitory receptors specifi  c for self-MHC 
molecules.       Blood      .     105  :  4416    –    4423  .    
NK cells were exposed to H-2D  d   cells, there was no down-
modulation of the Ly49D receptor on these cells (  34  ). Studies 
of the functional responses of these Ly49D  +   NK cells devel-
oping in H-2D  d    –  bearing hosts are complicated by the fact 
that a majority of Ly49D  +   NK cells coexpress inhibitory Ly49 
receptors, such as Ly49A, Ly49C, Ly49I, and Ly49G2, that 
also recognize H-2D  d   as a ligand. Moreover, although func-
tional studies indicate that H-2D  d   is a ligand for Ly49D (  35, 
36  ), there has as yet been no evidence that Ly49D can directly 
bind to H-2D  d   (  37  ). Indeed, we have failed to observe acti-
vation of NFAT-GFP reporter cells expressing Ly49D and 
DAP12 co-cultured with H-2D  d    –  bearing cells (unpublished 
data). These results suggest that Ly49D is likely a very low af-
fi  nity receptor for H-2D  d  , much less than the affi   nity of the 
inhibitory Ly49 receptors binding to H-2D  d  . In contrast, 
there is no evidence that Ly49H binds to any known H-2 
  ligand, but it does bind with high affi   nity to m157 (  12  ). 
Therefore, in establishing a model system to explore the con-
sequences of engaging an ITAM-signaling Ly49 receptor with 
a high affi   nity ligand on NK cell development, Ly49H and 
m157 provide a much simpler and better-defi  ned receptor  –
  ligand pair to address these questions. 
  As we are beginning to uncover the events that dictate 
survival and function in NK cell development, further studies 
are required to elucidate the precise molecular mechanisms 
and signals by which NK cells mature and become eff  ector 
cells in peripheral organs. Understanding the regulatory mech-
anisms at work during NK cell development that safeguard 
against peripheral autoimmunity will have important clin-
ical implications. 
  MATERIALS AND METHODS 
  Mice.     C57BL/6 and congenic (CD45.1) mice were purchased from the 
National Cancer Institute.   Rag2      /          ×   IL-2R common  –       chain      /      B6 mice 
were purchased from Taconic. B6 DAP12-defi   cient mice were bred at 
UCSF. Experiments were performed according to the UCSF Institutional 
Animal Care and Use Committee guidelines. 
  Retroviral vectors.     m157 was cloned into the MigR1 vector, and virus 
was generated using the Phoenix ecotropic packaging cell line (  38  ). Cells 
were incubated for 24  –  48 h, and analyzed for expression of m157 surface 
protein by fl  ow cytometry and by culturing overnight with Ly49H-NFAT-
GFP reporter cells, as previously described (  7  ). An empty MigR1 vector 
containing only GFP was used as a control. 
  Bone marrow chimeric mice.     Retrovirus supernatant was added to B6 
bone marrow cells (  38  ) with 4   μ  g/ml of polybrene in 6-well culture dishes 
and spun at 1,300   g   for 2 h at 37  °  C. After centrifugation, cells were incu-
bated overnight and the transduction was repeated the following day. On the 
fourth day, 10  6   cells were injected into lethally irradiated (1,000 rad) mice 
maintained on antibiotic water. Rag2      /        ×       c      /      or DAP12-defi  cient B6 
mice were used as recipients because they contain no NK cells (  39, 40  ) or 
express Ly49H  +   NK cells that respond ineffi   ciently to MCMV, respectively. 
Note that a subset of DAP12-defi  cient NK cells express very low levels of 
Ly49H on the cell surface (  19  ). 
  Flow cytometry and intracellular staining.     Cells were directly stained 
with antibodies against m157, NK1.1, DX5, CD3, Ly5.1, Ly49H, Ly49D, 
NKG2D, CD69, KLRG1, c-Kit, CD43, and Mac-1 (CD11b; all obtained 
from eBioscience or BD Biosciences). Anti-m157 and anti-Ly49H were 1828 NK CELL TOLERANCE   | Sun and Lanier 
crete subset of natural killer cells reactive with monoclonal antibody to 
Ly49H.       J. Exp. Med.       194  :  29    –    44  .    
        26  .   Andrews  ,   D.M.  ,   A.A.     Scalzo  ,   W.M.     Yokoyama  ,   M.J.     Smyth  , and   M.A.   
  Degli-Esposti  .   2003  .   Functional interactions between dendritic cells and 
NK cells during viral infection.       Nat. Immunol.       4  :  175    –    181  .    
        27  .   O  ’  Leary  ,   J.G.  ,   M.     Goodarzi  ,   D.L.     Drayton  , and   U.H.     von Andrian  . 
  2006  .   T cell- and B cell-independent adaptive immunity mediated by 
natural killer cells.       Nat. Immunol.       7  :  507    –    516  .    
        28  .   Tripathy  ,   S.K.  ,   P.A.     Keyel  ,   L.     Yang  ,   J.T.     Pingel  ,   T.P.     Cheng  ,   A.   
  Schneeberger  , and   W.M.     Yokoyama  .   2008  .   Continuous engagement 
of a self-specifi  c activation receptor induces NK cell tolerance.       J. Exp. 
Med.       205  :  1829    –    1841  .   
        29  .   Lee  ,   S.-H.  ,   S.     Gerard  ,   D.     Macina  ,   M.     Busa  ,   A.     Zafer  ,   A.     Belouchi  ,   P.   
  Gros  , and   S.M.     Vidal  .   2001  .   Susceptibility to mouse cytomegalovirus is 
associated with depletion of an activating natural killer cell receptor of 
the C-type lectin superfamily.       Nat. Genet.       28  :  42    –    45  .    
        30  .   Ogasawara  ,   K.  ,   J.     Benjamin  ,   R.     Takaki  ,   J.H.     Phillips  , and   L.L.     Lanier  . 
  2005  .   Function of NKG2D in natural killer cell-mediated rejection of 
mouse bone marrow grafts.       Nat. Immunol.       6  :  938    –    945  .    
        31  .   Oppenheim  ,   D.E.  ,   S.J.     Roberts  ,   S.L.     Clarke  ,   R.     Filler  ,   J.M.     Lewis  ,   R.E.   
  Tigelaar  ,  M.    Girardi  , and  A.C.    Hayday  .  2005  .  Sustained localized expression 
of ligand for the activating NKG2D receptor impairs natural cytotoxicity in 
vivo and reduces tumor immunosurveillance.       Nat. Immunol.       6  :  928    –    937  .    
        32  .   Vilarinho  ,   S.  ,   K.     Ogasawara  ,   S.     Nishimura  ,   L.L.     Lanier  , and   J.L.     Baron  . 
  2007  .   Blockade of NKG2D on NKT cells prevents hepatitis and the 
acute immune response to hepatitis B virus.       Proc. Natl. Acad. Sci. USA      .   
  104    :    18187      –      18192  .   
        33  .   George  ,   T.C.  ,   J.R.     Ortaldo  ,   S.     Lemieux  ,   V.     Kumar  , and   M.     Bennett  . 
  1999  .   Tolerance and alloreactivity of the Ly49D subset of murine NK 
cells.       J. Immunol.       163  :  1859    –    1867  .   
        34  .   Zhao  ,   Y.  ,   H.     Ohdan  ,   J.O.     Manilay  , and   M.     Sykes  .   2003  .   NK cell toler-
ance in mixed allogeneic chimeras.       J. Immunol.       170  :  5398    –    5405  .   
        35  .   George  ,   T.C.  ,   L.H.     Mason  ,   J.R.     Ortaldo  ,   V.     Kumar  , and   M.     Bennett  . 
  1999  .   Positive recognition of MHC class I molecules by the Ly49D 
receptor of murine NK cells.       J. Immunol.       162  :  2035    –    2043  .   
        36  .   Nakamura  ,   M.C.  ,   P.A.     Linnemeyer  ,   E.C.     Niemi  ,   L.H.     Mason  ,   J.R.   
  Ortaldo  ,   J.C.     Ryan  , and   W.E.     Seaman  .   1999  .   Mouse Ly-49D recog-
nizes H-2Dd and activates natural killer cell cytotoxicity.       J. Exp. Med.     
  189  :  493    –    500  .    
        37  .   Hanke  ,   T.  ,   H.     Takizawa  ,   C.W.     McMahon  ,   D.H.     Busch  ,   E.G.     Pamer  , 
  J.D.     Miller  ,   J.D.     Altman  ,   Y.     Liu  ,   D.     Cado  ,   F.A.     Lemonnier  ,   et al  .   1999  . 
  Direct assessment of MHC class I binding by seven Ly49 inhibitory NK 
cell receptors.       Immunity      .     11  :  67    –    77  .    
        38  .   Sun  ,   J.C.  ,   S.M.     Lehar  , and   M.J.     Bevan  .   2006  .   Augmented IL-7 signal-
ing during viral infection drives greater expansion of eff  ector T cells but 
does not enhance memory.       J. Immunol.       177  :  4458    –    4463  .   
        39  .   Cao  ,   X.  ,   E.W.     Shores  ,   J.     Hu-Li  ,   M.R.     Anver  ,   B.L.     Kelsall  ,   S.M.     Russell  , 
  J.     Drago  ,   M.     Noguchi  ,   A.     Grinberg  ,   E.T.     Bloom  ,   et al  .   1995  .   Defective 
lymphoid development in mice lacking expression of the common cy-
tokine receptor gamma chain.       Immunity      .     2  :  223    –    238  .    
        40  .   DiSanto  ,   J.P.  ,   W.     Muller  ,   D.     Guy-Grand  ,   A.     Fischer  , and   K.     Rajewsky  . 
  1995  .  Lymphoid development in mice with a targeted deletion of the inter-
leukin 2 receptor gamma chain.       Proc. Natl. Acad. Sci. USA      .     92  :  377    –    381  .    
        41  .   Sun  ,   J.C.  ,   M.A.     Williams  , and   M.J.     Bevan  .   2004  .   CD4+ T cells are 
required for the maintenance, not programming, of memory CD8+ T 
cells after acute infection.       Nat. Immunol.       5  :  927    –    933  .    
        42  .   Hesslein  ,   D.G.  ,   R.     Takaki  ,   M.L.     Hermiston  ,   A.     Weiss  , and   L.L.     Lanier  . 
  2006  .   Dysregulation of signaling pathways in CD45-defi  cient NK cells 
leads to diff  erentially regulated cytotoxicity and cytokine production.   
    Proc. Natl. Acad. Sci. USA      .     103  :  7012    –    7017  .    
        43  .   Cerwenka  ,   A.  ,   A.B.     Bakker  ,   T.     McClanahan  ,   J.     Wagner  ,   J.     Wu  ,   J.H.   
  Phillips  , and   L.L.     Lanier  .   2000  .   Retinoic acid early inducible genes 
defi  ne a ligand family for the activating NKG2D receptor in mice.   
    Immunity      .     12  :  721    –    727  .                          
       4  .   Yokoyama  ,   W.M.  , and   S.     Kim  .   2006  .   How do natural killer cells fi  nd 
self to achieve tolerance?       Immunity      .     24  :  249    –    257  .    
       5  .   Raulet  ,   D.H.     2006  .   Missing self recognition and self tolerance of natural 
killer (NK) cells.       Semin. Immunol.       18  :  145    –    150  .    
       6  .   Raulet  ,   D.H.  , and   R.E.     Vance  .   2006  .   Self-tolerance of natural killer 
cells.       Nat. Rev. Immunol.       6  :  520    –    531  .    
       7  .   Arase  ,   H.  ,   E.S.     Mocarski  ,   A.E.     Campbell  ,   A.B.     Hill  , and   L.L.     Lanier  . 
  2002  .   Direct recognition of cytomegalovirus by activating and inhibi-
tory NK cell receptors.       Science      .     296  :  1323    –    1326  .    
       8  .   Smith  ,   H.R.  ,   J.W.     Heusel  ,   I.K.     Mehta  ,   S.     Kim  ,   B.G.     Dorner  ,   O.V.   
  Naidenko  ,   K.     Iizuka  ,   H.     Furukawa  ,   D.L.     Beckman  ,   J.T.     Pingel  ,   et al  . 
  2002  .   Recognition of a virus-encoded ligand by a natural killer cell 
activation receptor.       Proc. Natl. Acad. Sci. USA      .     99  :  8826    –    8831  .   
       9  .   Brown  ,   M.G.  ,   A.O.     Dokun  ,   J.W.     Heusel  ,   H.R.     Smith  ,   D.L.     Beckman  , 
  E.A.     Blattenberger  ,   C.E.     Dubbelde  ,   L.R.     Stone  ,   A.A.     Scalzo  , and   W.M.   
  Yokoyama  .   2001  .   Vital involvement of a natural killer cell activation 
receptor in resistance to viral infection.       Science      .     292  :  934    –    937  .    
        10  .   Starr  ,   T.K.  ,   S.C.     Jameson  , and   K.A.     Hogquist  .   2003  .   Positive and neg-
ative selection of T cells.       Annu. Rev. Immunol.       21  :  139    –    176  .    
        11  .   Cambier  ,   J.C.  ,   S.B.     Gauld  ,   K.T.     Merrell  , and   B.J.     Vilen  .   2007  .   B-cell 
anergy: from transgenic models to naturally occurring anergic B cells?   
    Nat. Rev. Immunol.       7  :  633    –    643  .    
        12  .   Adams  ,   E.J.  ,   Z.S.     Juo  ,   R.T.     Venook  ,   M.J.     Boulanger  ,   H.     Arase  ,   L.L.   
  Lanier  , and   K.C.     Garcia  .   2007  .   Structural elucidation of the m157 
mouse cytomegalovirus ligand for Ly49 natural killer cell receptors.       Proc. 
Natl. Acad. Sci. USA      .     104  :  10128    –    10133  .    
        13  .   Tripathy  ,   S.K.  ,   H.R.     Smith  ,   E.A.     Holroyd  ,   J.T.     Pingel  , and   W.M.   
  Yokoyama  .   2006  .   Expression of m157, a murine cytomegalovirus-
encoded putative major histocompatibility class I (MHC-I)-like pro-
tein, is independent of viral regulation of host MHC-I.       J. Virol.       80  :
  545    –    550  .    
        14  .   Smith  ,   H.R.  ,   H.H.     Chuang  ,   L.L.     Wang  ,   M.     Salcedo  ,   J.W.     Heusel  , and 
  W.M.     Yokoyama  .   2000  .   Nonstochastic coexpression of activation re-
ceptors on murine natural killer cells.       J. Exp. Med.       191  :  1341    –    1354  .    
        15  .   Rosmaraki  ,   E.E.  ,   I.     Douagi  ,   C.     Roth  ,   F.     Colucci  ,   A.     Cumano  , and   J.P.   
  Di Santo  .   2001  .   Identifi  cation of committed NK cell progenitors in 
adult murine bone marrow.       Eur. J. Immunol.       31  :  1900    –    1909  .    
        16  .   Colucci  ,   F.  ,   M.A.     Caligiuri  , and   J.P.     Di Santo  .   2003  .   What does it take 
to make a natural killer?       Nat. Rev. Immunol.       3  :  413    –    425  .    
        17  .   Vosshenrich  ,   C.A.  ,   S.I.     Samson-Villeger  , and   J.P.     Di Santo  .   2005  . 
  Distinguishing features of developing natural killer cells.       Curr. Opin. 
Immunol.       17  :  151    –    158  .    
        18  .   Kim  ,   S.  ,   K.     Iizuka  ,   H.S.     Kang  ,   A.     Dokun  ,   A.R.     French  ,   S.     Greco  , and 
  W.M.     Yokoyama  .   2002  .   In vivo developmental stages in murine natural 
killer cell maturation.       Nat. Immunol.       3  :  523    –    528  .    
        19  .   Bakker  ,   A.B.  ,   R.M.     Hoek  ,   A.     Cerwenka  ,   B.     Blom  ,   L.     Lucian  ,   T.   
  McNeil  ,   R.     Murray  ,   L.H.     Phillips  ,   J.D.     Sedgwick  , and   L.L.     Lanier  . 
  2000  .   DAP12-defi  cient mice fail to develop autoimmunity due to im-
paired antigen priming.       Immunity      .     13  :  345    –    353  .    
        20  .   Huntington  ,   N.D.  ,   H.     Tabarias  ,   K.     Fairfax  ,   J.     Brady  ,   Y.     Hayakawa  , 
  M.A.     Degli-Esposti  ,   M.J.     Smyth  ,   D.M.     Tarlinton  , and   S.L.     Nutt  . 
  2007  .   NK cell maturation and peripheral homeostasis is associated with 
KLRG1 up-regulation.       J. Immunol.       178  :  4764    –    4770  .   
        21  .   Lanier  ,   L.L.     2005  .   NK cell recognition.       Annu. Rev. Immunol.     
  23  :  225    –    274  .    
        22  .   Yokoyama  ,   W.M.  ,   S.     Kim  , and   A.R.     French  .   2004  .   The dynamic life of 
natural killer cells.       Annu. Rev. Immunol.       22  :  405    –    429  .    
        23  .   Di Santo  ,   J.P.     2006  .   Natural killer cell developmental pathways: a ques-
tion of balance.       Annu. Rev. Immunol.       24  :  257    –    286  .    
        24  .   Dokun  ,   A.O.  ,   S.     Kim  ,   H.R.     Smith  ,   H.S.     Kang  ,   D.T.     Chu  , and   W.M.   
  Yokoyama  .   2001  .   Specifi  c and nonspecifi  c NK cell activation during 
virus infection.       Nat. Immunol.       2  :  951    –    956  .    
        25  .   Daniels  ,   K.A.  ,   G.     Devora  ,   W.C.     Lai  ,   C.L.     O  ’  Donnell  ,   M.     Bennett  , 
and   R.M.     Welsh  .   2001  .   Murine cytomegalovirus is regulated by a dis-